Early last year, a hundred researchers, clinicians and other experts on HIV discussed the development of an innovative vaccine that could prevent the disease. But just as the meeting was about to wrap up, the mood darkened. A new executive order signed by President Trump on Inauguration day had frozen all foreign aid, pending a review. Soon, DOGE would begin its
decimation of USAID — and with it, this vaccine trial. That is – until the South African researchers came up with a new plan.
Read more of freelance science reporter Ari Daniel’s story here.This story was supported by a grant from the Pulitzer Center.Interested in more on the future of science? Email us your question at shortwave@npr.org.Listen to every episode of Short Wave sponsor-free and support our work at NPR by signing up for Short Wave+ at plus.npr.org/shortwave.To manage podcast ad preferences, review the links below:
See
pcm.adswizz.com for information about our collection and use of personal data for sponsorship and to manage your podcast sponsorship preferences.
NPR Privacy Policy
